A rat model of chronic kidney disease-mineral bone disorder

被引:124
|
作者
Moe, Sharon M. [1 ,2 ]
Chen, Neal X. [1 ]
Seifert, Mark F. [3 ]
Sinders, Rachel M. [3 ]
Duan, Dana [1 ]
Chen, Xianming [1 ]
Liang, Yun [4 ]
Radcliff, J. Scott [5 ]
White, Kenneth E. [6 ]
Gattone, Vincent H., II [3 ]
机构
[1] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46260 USA
[2] Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA
[3] Indiana Univ, Sch Med, Dept Anat, Indianapolis, IN 46260 USA
[4] Indiana Univ, Sch Med, Dept Radiol, Indianapolis, IN 46260 USA
[5] Purdue Univ, Dept Anim Sci, Lafayette, IN USA
[6] Indiana Univ, Sch Med, Dept Genet, Indianapolis, IN 46260 USA
关键词
vascular calcification; renal osteodystrophy; chronic kidney disease; hyperphosphatemia; hyperparathyroidism; CORONARY-ARTERY CALCIFICATION; SUBTOTALLY NEPHRECTOMIZED RATS; CHRONIC-RENAL-FAILURE; VASCULAR CALCIFICATION; SECONDARY HYPERPARATHYROIDISM; SEVELAMER HYDROCHLORIDE; CALCIUM-CARBONATE; PROTEIN-DIET; UREMIC RATS; PROGRESSION;
D O I
10.1038/ki.2008.456
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD) is a newly defined syndrome encompassing patients with chronic kidney disease that have a triad of biochemical alterations in calcium, phosphorus and parathyroid hormone, vascular calcification, and bone abnormalities. Here we describe a novel Cy/+ rat model of slowly progressive kidney disease spontaneously developing the three components of CKD-MBD when fed a normal phosphorus diet. Since the renal disorder progressed 'naturally' we studied the effect of dietary manipulation during the course of the disease. Animals with early, but established, chronic kidney disease were fed a casein-based or a grain-based protein diet both of which had equivalent total phosphorus contents. The two different sources of dietary protein had profound effects on the progression of CKD-MBD, likely due to differences in intestinal bioavailability of phosphorus. Although both dietary treatments resulted in the same serum phosphorous levels, the casein-fed animals had increased urinary phosphorus excretion and elevated serum FGF23 compared to the grain-fed rats. This model should help identify early changes in the course of chronic kidney disease that may lead to CKD-MBD.
引用
收藏
页码:176 / 184
页数:9
相关论文
共 50 条
  • [41] Bone health in chronic kidney disease-mineral and bone disease
    Gal-Moscovici, Anca
    Sprague, Stuart M.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2007, 14 (01) : 27 - 36
  • [42] EVALUATION OF CHILDREN WITH KIDNEY TRANSPLANTATION IN TERMS OF CHRONIC KIDNEY DISEASE-MINERAL BONE DISORDER
    Alpay, Ayse
    Yildirim, Zeynep Yuruk
    Kucukgergin, Canan
    Aydin, Fatih
    Aksu, Bagdagul
    Yilmaz, Alev
    Nayir, Ahmet
    PEDIATRIC NEPHROLOGY, 2023, 38 : S112 - S113
  • [43] Metformin prevents from severe kidney failure, vascular calcification and high bone turnover disease in a rat model for chronic kidney disease-mineral and bone disorder
    D'Haese, P.
    Vervaet, B.
    Brand, K.
    Gottwald-Hostalek, U.
    Dams, G.
    Verhulst, A.
    Lalau, J. -D.
    Said, K.
    De Broe, M. E.
    Neven, E.
    DIABETOLOGIA, 2016, 59 : S485 - S486
  • [44] Clinical Practice Guideline for the Management of Chronic Kidney Disease-Mineral and Bone Disorder
    Fukagawa, Masafumi
    Yokoyama, Keitaro
    Koiwa, Fumihiko
    Taniguchi, Masatomo
    Shoji, Tetsuo
    Kazama, Junichiro James
    Komaba, Hirotaka
    Ando, Ryoichi
    Kakuta, Takatoshi
    Fujii, Hideki
    Nakayama, Msasaaki
    Shibagaki, Yugo
    Fukumoto, Seiji
    Fujii, Naohiko
    Hattori, Motoshi
    Ashida, Akira
    Iseki, Kunitoshi
    Shigematsu, Takashi
    Tsukamoto, Yusuke
    Tsubakihara, Yoshiharu
    Tomo, Tadashi
    Hirakata, Hideki
    Akizawa, Tadao
    THERAPEUTIC APHERESIS AND DIALYSIS, 2013, 17 (03) : 247 - 288
  • [45] The current status of chronic kidney disease-mineral and bone disorder management in China
    Ya Zhan
    Xin He
    Daqing Hong
    Li Wang
    Guisen Li
    Scientific Reports, 12
  • [46] The role of activin: the other side of chronic kidney disease-mineral bone disorder?
    Cianciolo, Giuseppe
    La Manna, Gaetano
    Capelli, Irene
    Gasperoni, Lorenzo
    Galassi, Andrea
    Ciceri, Paola
    Cozzolino, Mario
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (06) : 966 - 974
  • [47] Current Concepts and Management Strategies in Chronic Kidney Disease-Mineral and Bone Disorder
    Chauhan, Veeraish
    Kelepouris, Ellie
    Chauhan, Nishtha
    Vaid, Megha
    SOUTHERN MEDICAL JOURNAL, 2012, 105 (09) : 479 - 485
  • [48] Early chronic kidney disease-mineral bone disorder stimulates vascular calcification
    Fang, Yifu
    Ginsberg, Charles
    Sugatani, Toshifumi
    Monier-Faugere, Marie-Claude
    Malluche, Hartmut
    Hruska, Keith A.
    KIDNEY INTERNATIONAL, 2014, 85 (01) : 142 - 150
  • [49] Is there a role for newer biomarkers in chronic kidney disease-mineral and bone disorder management?
    Tan, Sven-Jean
    Cai, Michael M. X.
    NEPHROLOGY, 2017, 22 : 14 - 18
  • [50] The WNT/β-catenin system in chronic kidney disease-mineral bone disorder syndrome
    Lingbo Zhang
    Isaac Kumi Adu
    Haifeng Zhang
    Jiancheng Wang
    International Urology and Nephrology, 2023, 55 : 2527 - 2538